{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:35Z","timestamp":1787020955087,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Faculty of Medicine Ramathibodi Hospital, Mahidol University","award":["ID 863"],"award-info":[{"award-number":["ID 863"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extended-spectrum b-lactamase (ESBL)-producing gram-negative bacilli (ESBL-GNB) are the most important pathogenic bacteria infecting kidney transplant patients. Kidney transplantation has been shown to be a risk factor for nosocomial ESBL-GNB bacteremia. The aims of this study were to describe the epidemiology of ESBL-GNB acquisition and to identify factors associated with ESBL-GNB infection in kidney transplant recipients, including pretransplant ESBL-GNB fecal carriage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective study of patients undergoing kidney transplantation at Ramathibodi Hospital from March 1, 2019\u2013November 30, 2020 was conducted. During this period, 66 patients who underwent kidney transplantation. Perianal swab cultures and urine cultures for ESBL-GNB were obtained from all subjects upon admission for transplantation and on Days 3, 7, 14 and 21 after surgery to determine the prevalence, incidence, and duration of admission before acquisition of the organisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 66 patients undergoing kidney transplantation, 18 preoperative perianal swabs were detected to be positive for ESBL-GNB upon admission, representing 27.3% of the cases. The in-hospital perianal swab tests showed a significant increase to 96.8% positive ESBL-GNB cultures at the end of week 3. Approximately one-fourth (27.8%) of patients who acquired ESBL-GNB developed a postoperative symptomatic infection. The infection occurred in 13% of such patients who were not ESBL positive at first. These infections included urinary tract infections (20 cases, [30%], of which 55% were due to ESBL-GNB) and bloodstream infections (13 cases; of which 9 [69.2%] were due to ESBL-GNB).\n                      <jats:italic>E. coli<\/jats:italic>\n                      was the most common pathogen. Previous exposure to antibiotics, including surgical prophylaxis, underlying disease, duration of indwelling urinary catheters and ureteric stents, as well as other operative factors were not found to be significantly associated with the acquisition of ESBL-producing organisms in this dataset.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ESBL carriage may be a risk factor for the development of bacteremia and other serious infections among kidney transplant recipients, although a statistically significant difference could not be demonstrated owing to the small size of the sample. The high rate of ESBL acquisition suggests that more stringent infection prevention and control efforts are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-023-01308-x","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T07:01:50Z","timestamp":1699599710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology of extended-spectrum \u03b2-lactamase\u2013producing Enterobacterales infection in kidney transplant recipients"],"prefix":"10.1186","volume":"12","author":[{"given":"Oranuch","family":"Promsuwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumthorn","family":"Malathum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiporn","family":"Ingsathit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"issue":"8","key":"1308_CR1","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/319757","volume":"32","author":"E Lautenbach","year":"2001","unstructured":"Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32(8):1162\u201371. https:\/\/doi.org\/10.1086\/319757. (Epub 2001\/04\/03).","journal-title":"Clin Infect Dis"},{"key":"1308_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.12659\/AOT.883901","volume":"18","author":"EJ Ariza-Heredia","year":"2013","unstructured":"Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transpl. 2013;18:195\u2013204. https:\/\/doi.org\/10.12659\/AOT.883901. (Epub 2013\/06\/26).","journal-title":"Ann Transpl"},{"issue":"8","key":"1308_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/TP.0b013e3182a04997","volume":"96","author":"JR Lee","year":"2013","unstructured":"Lee JR, Bang H, Dadhania D, Hartono C, Aull MJ, Satlin M, et al. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation. 2013;96(8):732\u20138. https:\/\/doi.org\/10.1097\/TP.0b013e3182a04997. (Epub 2013\/08\/07).","journal-title":"Transplantation"},{"issue":"10","key":"1308_CR4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3109\/23744235.2015.1051107","volume":"47","author":"B Pilmis","year":"2015","unstructured":"Pilmis B, Scemla A, Join-Lambert O, Mamzer MF, Lortholary O, Legendre C, et al. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence. Infect Dis (Lond). 2015;47(10):714\u20138. https:\/\/doi.org\/10.3109\/23744235.2015.1051107. (Epub 2015\/05\/30).","journal-title":"Infect Dis (Lond)"},{"key":"1308_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12718","author":"M Alevizakos","year":"2017","unstructured":"Alevizakos M, Kallias A, Flokas ME, Mylonakis E. Colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae in solid organ transplantation: A meta-analysis and review. Transpl Infect Dis. 2017. https:\/\/doi.org\/10.1111\/tid.12718. (Epub 2017\/05\/05).","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"1308_CR6","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1600-6143.2008.02197.x","volume":"8","author":"L Linares","year":"2008","unstructured":"Linares L, Cervera C, Cofan F, Lizaso D, Marco F, Ricart MJ, et al. Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant. 2008;8(5):1000\u20135. https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02197.x. (Epub 2008\/08\/30).","journal-title":"Am J Transplant"},{"issue":"6","key":"1308_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/ctr.12366","volume":"28","author":"EJ Ariza-Heredia","year":"2014","unstructured":"Ariza-Heredia EJ, Beam EN, Lesnick TG, Cosio FG, Kremers WK, Razonable RR. Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant. 2014;28(6):683\u201390. https:\/\/doi.org\/10.1111\/ctr.12366. (Epub 2014\/03\/25).","journal-title":"Clin Transplant"},{"issue":"10","key":"1308_CR8","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1128\/JCM.42.10.4769-4775.2004","volume":"42","author":"A Valverde","year":"2004","unstructured":"Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol. 2004;42(10):4769\u201375. https:\/\/doi.org\/10.1128\/JCM.42.10.4769-4775.2004. (Epub 2004\/10\/09).","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1308_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/jac\/dks118","volume":"67","author":"UO Luvsansharav","year":"2012","unstructured":"Luvsansharav UO, Hirai I, Nakata A, Imura K, Yamauchi K, Niki M, et al. Prevalence of and risk factors associated with faecal carriage of CTX-M beta-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother. 2012;67(7):1769\u201374. https:\/\/doi.org\/10.1093\/jac\/dks118. (Epub 2012\/04\/20).","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1308_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1086\/500936","volume":"42","author":"R Ben-Ami","year":"2006","unstructured":"Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, et al. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis. 2006;42(7):925\u201334. https:\/\/doi.org\/10.1086\/500936. (Epub 2006\/03\/03).","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1308_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1086\/597505","volume":"30","author":"R Friedmann","year":"2009","unstructured":"Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, et al. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30(6):534\u201342. https:\/\/doi.org\/10.1086\/597505. (Epub 2009\/05\/08).","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1308_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/mdr.2006.12.50","volume":"12","author":"IS Martins","year":"2006","unstructured":"Martins IS, Pessoa-Silva CL, Nouer SA, Pessoa de Araujo EG, Ferreira AL, Riley LW, et al. Endemic extended-spectrum beta-lactamase-producing Klebsiella pneumoniae at an intensive care unit: risk factors for colonization and infection. Microb Drug Resist. 2006;12(1):50\u20138. https:\/\/doi.org\/10.1089\/mdr.2006.12.50. (Epub 2006\/04\/06).","journal-title":"Microb Drug Resist"},{"issue":"7","key":"1308_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1086\/521260","volume":"45","author":"P Reddy","year":"2007","unstructured":"Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis. 2007;45(7):846\u201352. https:\/\/doi.org\/10.1086\/521260. (Epub 2007\/09\/07).","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1308_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/604713","volume":"49","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009;49(5):682\u201390. https:\/\/doi.org\/10.1086\/604713. (Epub 2009\/07\/23).","journal-title":"Clin Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01308-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-023-01308-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01308-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T07:07:56Z","timestamp":1699600076000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-023-01308-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1186\/s13756-023-01308-x","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"26 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Faculty of Medicine Ramathibodi Hospital, Mahidol University (ID 863). There are human subject in this study and informed consent for participation was applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}